Project Description

Although therapies are limited and a cure remains elusive, the onset of Alzheimer’s disease (AD) can now be predicted with a degree of accuracy years in advance.  Prediction is currently used for research purposes.  Professor Wolk explains how brain images and blood or CSF biomarkers can be used for prediction, how accurate these measures are at present, why the focus on early, presymptomatic phases of the disease is changing how we think of AD, and how the availability of clinical tests for incipient AD may change life for older persons.

Slides for this video can be found here.